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Rho family guanosine triphosphatase (GTPase) 3 (Rnd3), amember of
the small RhoGTPase family, is involved in the regulation of cell actin
cytoskeleton dynamics, cell migration, and proliferation through the
Rho kinase-dependent signaling pathway. We report a role of Rnd3
in the pathogenesis of hydrocephalus disorder. Mice with Rnd3 ge-
netic deletion developed severe obstructive hydrocephalus with en-
largement of the lateral and third ventricles, but not of the fourth
ventricles. The cerebral aqueducts in Rnd3-null mice were partially or
completely blocked by the overgrowth of ependymal epithelia. We
examined the molecular mechanism contributing to this Rnd3-defi-
ciency–mediated hydrocephalus and found that Rnd3 is a regulator
of Notch signaling. Rnd3 deficiency, through either gene deletion or
siRNA knockdown, resulted in a decrease in Notch intracellular do-
main (NICD) protein degradation. However, there was no correlated
change in mRNA change, which in turn led to an increase in NICD
protein levels. Immunoprecipitation analysis demonstrated that
Rnd3 and NICD physically interacted, and that down-regulation of
Rnd3 attenuated NICD protein ubiquitination. This eventually en-
hanced Notch signaling activity and promoted aberrant growth of
aqueduct ependymal cells, resulting in aqueduct stenosis and the
development of congenital hydrocephalus. Inhibition of Notch activ-
ity rescued the hydrocephalus disorder in the mutant animals.
developmental brain defect | genetic mouse model | post-translational
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The cerebrospinal fluid (CSF) flow tract is a dynamic circulatorysystem that supplies the brain with essential nutrients and
growth factors throughout development and into adulthood (1).
Ependymal cells, specified epithelial cells that line the aqueduct
and cerebral ventricles of mammalian species, make up the CSF
tract and propel CSF flow (2, 3). Malformation of the ependymal
epithelium can lead to failure of cerebral irrigation and a buildup
of CSF in the ventricular cavities of the brain, a pathological
condition known as hydrocephalus.
Hydrocephalus in humans is a severe neurologic disorder
characterized by an excessive accumulation of CSF in the brain. It
affects approximately 1 in every 500 children, based on estimates
from the National Institute of Neurological Disorders and Stroke.
The precise causes of hydrocephalus remain largely unknown.
Accumulating evidence suggests that genetic factors are critical to
the pathogenesis of hydrocephalus. Congenital hydrocephalus,
caused by genetic abnormalities, is the most common type.
Aqueductal stenosis is the major contributing factor in congenital
hydrocephalus, with an prevalence of 0.1–0.3% of all live births
(4). At least nine genes have been identified as closely associated
with the pathogenesis of congenital hydrocephalus in animal
studies, but few of these genes have been verified in humans (5–8).
Continued identification of new genes/loci linked to congenital
hydrocephalus will expand our knowledge of the genetic compo-
nents of this disorder.
Rho family GTPase 3 (Rnd3, also known as RhoE) was origi-
nally defined as a repressor of Rho protein kinase 1 (ROCK1) (9,
10). Initial studies of Rnd3 focused mainly on its inhibitory effect
on Rho kinase-mediated biological functions, including actin cy-
toskeleton formation, myosin light chain phosphatase phosphor-
ylation, and apoptosis (9–11). Recent studies have identified Rnd3
as essential in mouse neuron development through its negative
regulation of the Rho signaling pathway (12, 13).
In this study, we demonstrated a different function of Rnd3.
Mice with a genetic deletion of Rnd3 developed aqueductal ste-
nosis, which led to the development of obstructive hydrocephalus
owing to hyperplasia of ependymal cells in the aqueducts. We also
identified the molecular mechanism of Rnd3 deficiency-induced
hydrocephalus and demonstrated that Rnd3 is a regulator of Notch
signaling. Rnd3 deficiency in animal studies and down-regulation
in cell culture experiments were associated with obvious decreases
in Notch intracellular domain (NICD) degradation, which in turn
led to an increase in NICD protein levels. This eventually pro-
moted Notch signaling activity and facilitated aqueduct ependymal
cell proliferation, resulting in aqueductal stenosis and the de-
velopment of congenital hydrocephalus. The pathogenesis of hy-
drocephalus was curtailed by the inhibition of Notch activity.
Results
High Expression of Rnd3 Was Detected in Mouse Brains, Particularly in
Ependymal Cells Lining Aqueducts and Ventricles. The generation of
Rnd3 KOmice is described inMaterials and Methods. The targeting
vector carried a β-gal expression cassette with an internal ribosomal
entry site. The endogenous levels of Rnd3 were detected by beta-
galactosidase (lacZ) staining, showing the universal expression of
Rnd3, with high expression levels in the CNS (Fig. 1A). Rnd3
transcript levels in various organs were assessed by quantitative
PCR (qPCR) and found to be consistent with the lacZ staining (Fig.
1B). Immunohistochemistry analysis revealed enriched expression
of Rnd3 in the ependymal cells lining the aqueductal lumina (Fig. 1
C and D) and the inner ventricle walls (Fig. 1 E and F).
Severe Hydrocephalus Was Caused by Aqueductal Stenosis Through
Aberrant Growth of Ependymal Cells as a Result of Genetic Deletion
of Rnd3. Rnd3−/− mice exhibited a dome-shaped skull (Fig. 2A).
A large amount of CSF drained out of the mutant mouse brain
during isolation (Fig. 2B). Significantly enlarged lateral ventricles
and remarkable thinning of the occipital cortex were observed
(Fig. 2C) and quantified (Fig. 2D). Further dissections revealed
the extremely dilated or broken third ventricles (Fig. 3 A and B)
along with the narrowed or even disconnected aqueduct (Fig. 3 C
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and D). No enlargement or dilation was seen in the fourth ven-
tricles. Examination of brain sagittal revealed stenosis and multi-
ple layers of ependymal cells at the aqueduct end in the mutant
mice (Fig. 3I), compared with the open aqueduct smoothly lined
with a single layer of ependymal cells in the WT mice (Fig. 3J).
These findings indicate that a severe noncommunicating hydro-
cephalus developed in the Rnd3-null mice, and that the aque-
ductal stenosis contributed to the genesis of this hydrocephalus
possibly through the overgrowth of ependymal cells.
Rnd3 Negatively Regulated Notch Signaling Through Interaction and
Degradation of NICD. To explore the molecular mechanism of
Rnd3 deficiency-mediated aqueductal ependymal cell overgrowth,
we conducted a pilot microarray assessment in the mutant mice,
which revealed significant up-regulation of Notch signaling (Figs.
S1 and S2 and Dataset S1). Thus, we analyzed the mutant mouse
brain, and found an increase in the levels of Hes1 protein (Fig.
4A). Hes1 is a Notch signaling target gene demonstrated to func-
tion as a p21 repressor to promote cell proliferation (14). Mean-
while, immunostaining specific for NICD, the active Notch
isoform, revealed a strong detection in the mutant mouse aque-
duct (Fig. 4B), along with strong immunostaining for Hes1 at the
same location (Fig. 4C). To evaluate the relationship between
Rnd3 and activation of Notch signaling, we used loss-of-function
and gain-of-function approaches for in vitro studies using HEK
293T cells. Rnd3 knockdown resulted in elevations of NICD and
Hes1 protein levels, along with histone 3 (His3) hyperphosphory-
lation (Fig. 4D, Left). The opposite results were achieved after the
cells were transfected with the Rnd3 expression vector (Fig. 4D,
Right). However, knockdown of Rnd3 failed to increase the NICD
(Notch1) mRNA levels, even though the Hes1 mRNA levels were
elevated (Fig. 4E). These data suggest that NICD is under post-
translational regulation through Rnd3.
Given that the ubiquitin-proteasome system (UPS) is a critical
posttranslational regulation mechanism for NICD, we investigated
whether Rnd3 plays a role in UPS-mediated NICD degradation.
We first examined the expression profiles of the two proteins, and
found that both Rnd3 and Notch1 receptors were highly expressed
in mouse aqueductal ependyma (Fig. 5A). We then explored the
interaction of Rnd3 and NICD ex vivo by cotransfection of myc-
Rnd3 and flag-NICD in HEK293T cells, followed by mutual
coimmunoprecipitation (Fig. 5 B and C). To evaluate the bi-
ological significance of the interaction of these two proteins, we
assessed the levels of NICD protein along with the increase in
Rnd3 expression. Immunoblot analysis revealed decreased NICD
protein levels when the cells expressed higher levels of Rnd3
(Fig. 5D, lanes 1–3). This process was significantly attenuated by
treatment with a proteasome inhibitor, MG132 (Fig. 5D, lanes
4–6). The enhanced NICD degradation after the introduction of
Rnd3 was verified by cycloheximide chase analysis. Lower en-
dogenous NICD protein levels were observed in cells transfected
with the Rnd3 expression vector compared with control cells
(Fig. 5E). These data provide evidence that Rnd3 interacts with
NICD and promotes UPS-mediated NICD degradation.
Inhibition of Notch Signaling Blocked Rnd3 Deficiency-Induced
Aqueductal Ependymal Cell Aberrant Growth and Prevented Hydro-
cephalus in Rnd3-Null Mice. Consistent with our early findings in-
dicating the overgrowth of aqueductal ependymal cells (Fig. 3I),
we detected a more intense immunostaining of phosphorylated
His3 (p-His3) in aqueducts of the mutant mice compared with
WT mice (Fig. 6A). To investigate whether the abnormal epen-
dymal cell proliferation, aqueductal stenosis, and eventual hy-
drocephalus observed in Rnd3-null mice could be rescued by the
inhibition of Notch signaling, we conducted in vitro and in vivo
experiments using compound E, a Notch signaling inhibitor. We
found that the knockdown of Rnd3 in HEK 293T cells led to
a significant increase in bromodeoxyuridine (BrdU)-positive cells,
and that this increase was completely impeded by the compound
E treatment (Fig. 6B).
Fig. 1. Expression of Rnd3 is universal and enriched in the CNS, with the
highest levels in the ependymal cells lining the aqueduct, lateral ventricle,
and third ventricle. (A) LacZ staining displayed Rnd3 expression in an E9.5
mouse. (B) Transcript levels of Rnd3 were quantified by qPCR analysis. (C and
D) Enriched expression of Rnd3 was detected in ependymal cells at an aq-
ueduct (Aq) region shown by lacZ staining (C, arrow) and by immunostaining
(D). (E and F) Ependymal cells at lateral ventricle (LV) (E) and third ventricle
(3V) (F) also displayed high expression levels of Rnd3. qPCR data were
pooled from four mice, with analyses for each organ done in triplicate. di,
diencephalon; ms, mesencephalon; mt, metencephalon; my, myelencepha-
lon; sc, spinal cord; te, telencephalon; Ht, heart; Sk, skeletal muscle; Ps,
prostate; Lv, Liver; Lg, lung; Ts, testis; Si, small intestine; Kd, kidney; Br, brain.
(Scale bars: 500 μm in C; 25 μm in D–F.)
Fig. 2. Rnd3-deficient mice developed hydrocephalus. (A) The mutant
mouse displayed a domed skull (white dashed line) compared with the WT
mouse. (B) A large amount of CSF was drained out during brain isolation,
and the global brains showed the enlarged hemispheres, compressed olfac-
tory bulbs, and subsided cerebral cortex in the mutant mice. (C) Represen-
tative brain coronal sections across the anterior commissure (ac) (Left) and
optical chiasm (ox) (Right) showed the extreme dilations of the LVs along
with a thin cerebral cortex in the mutant mice (Upper) compared with the
WT mice (Lower). The brain sections were stained with H&E. (D and E) The
area of the LV (D) and the thickness of the cerebral cortex (E) were quan-
tified from a total of 12 staining pictures taken from six brains from 6-wk-old
mice in each group. *P < 0.05 vs. WT.
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For the animal rescue experiments, because mouse aqueduct
development starts at E13.5, we delivered compound E into 10
pregnant mice at E12.5 through i.p. injection until birth. We found
no development of hydrocephalus in the newborn Rnd3-null mice
(Fig. 7A). An open aqueduct, smoothly lined with a single layer of
ependymal cells, was observed in the compound E-treated Rnd3-
null mice (Fig. 7B). As expected, lower expression of Hes1 protein
was detected in the mouse brain tissues after compound E treat-
ment (Fig. 7 C and D). Thus, the inhibition of Notch signaling by
compound E treatment is sufficient to abolish the development of
hydrocephalus in mice caused by Rnd3 deficiency.
Discussion
Notch receptor is a single-pass transmembrane protein involved in
numerous biological processes, particularly cell-to-cell signaling
communication. Notch activation consists of multiple cascade
processes. In brief, the binding of Notch receptor to its ligand
triggers two proteolytic cleavages. The initial cleavage removes the
extracellular domain of Notch by a metalloprotease α-secretase,
and the second cleavage is catalyzed by a presenilin/γ-secretase
complex within the transmembrane domain of Notch. The pro-
teolysis releases an activeNotch isoform, NICD, which translocates
to the nucleus. In the nucleus, NICD forms a transcriptional com-
plex with other factors, including mastermind-like protein (Maml)
and CSL (CBF1, suppressor of hairless, Lag-1), to regulate down-
stream target genes, including hairy and enhancer of split-1 (Hes1)
and Hes5 (Fig. 8). Dysregulation of Notch signaling results in
severe neurogenesis, including hydrocephalus during development
(15, 16).
Fig. 3. Dilated third ventricle and stenotic aqueduct in Rnd3-deficient mice.
(A–H) Brain coronal sections with H&E staining displayed an enlarged (A) or
damaged (B) third ventricle (3V) and stenotic (C) or completely blocked (D)
aqueduct in 6-wk-old Rnd3−/− mice compared with WT control mice in the
identical areas (E–H, respectively). SCO, subcommissural organ; Ox, optic
chiasm; Aq, aqueduct. (Scale bars: 500 μm.) (I and J) The stenotic aqueduct
was viewed in sagittal sections with DAPI staining. The stenosis (arrow) and
multiple layers of ependymal cells (arrowhead) at the end of the aqueduct
were detected in the mutant mice (I), but not in the WT control mice (J). The
left and right sections in panels I and J represent different layers of the same
brain, respectively. (Insets) Lower-magnification views of the same areas
shown in I and J. (Scale bars: 50 μm.) 4V, fourth ventricle.
Fig. 4. Rnd3 negatively regulated Notch signaling at protein expression
levels. (A) Protein expression level from the Notch signaling target gene,Hes1,
was significantly increased in the brain tissues of Rnd3-null mice compared
with theWT control mice. This up-regulation was quantified and presented in
the right panel of this section. (B and C) Marked increases in NICD (B) and Hes1
(C) immunostainingwere seen in the aqueduct (Aq) from a 6-wk-old Rnd3-null
mouse compared with a WT control mouse. (D) Immunoblot analyses showed
that the down-regulation of Rnd3 resulted in increases in the Notch1 active
form NICD, Notch target gene Hes1, and p-His3 expression levels in HEK 293T
cells. The opposite results were observed on Rnd3 overexpression. The number
at the top of each band represents the average of densitometries from three
experiments, normalized by GAPDH. (E) qPCR analysis indicated no change in
Notch1, but elevated Hes1 transcript levels by Rnd3 knockdown. The data
were pooled from three experiments, with analyses for each in triplicate.
(Scale bar: 10 μm.) *P < 0.05 vs. control or WT.
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An aqueduct is the narrowest part in CSF circulation tunnels.
Aqueductal stenosis is considered the major cause of congenital hydrocephalus (4). Because of this tight anatomic structure,
aqueducts are susceptible to many pathological conditions that
result in aqueductal stenosis, such as the overgrowth of ependymal
cells. Ependymal cells are a single layer of neuroepithelial cells
lining the wall of the aqueductal lumen, as well as the ventricles.
Duringmouse embryonic development, the ependymal epithelium
is derived from the neuroepithelial cells lining the lumen of the
dorsal-caudal aspect of the diencephalon. Proliferation and dif-
ferentiation of primitive neuroepithelial progenitors are driven
toward a specialized ependymal cell fate under the control of
numerous signal pathways, including Notch signaling.
Several previous studies have demonstrated that the normal
function of Notch signaling is crucial for neuroepithelial cell
growth. Lethal giant larvae 1 (Lgl1) is a negative Notch regulator.
Neuroepithelial cells with Lgl1 deficiency were hyperproliferative
with high Notch activity, and the Lgl1-null mice even developed
severe hydrocephalus at the embryonic stage (15). Genetic de-
letion of another Notch antagonist protein, numb homolog gene
Numb or Numblike (Numbl), also led to obstructive hydroceph-
alus owing to the multilayered stratified epithelium developed in
the CSF circulation tunnels (16). Numb promoted Notch receptor
ubiquitination, which in turn facilitatedNotch protein degradation
(17). Interestingly, Lgl1 and Numb/Numbl act in concert to regulate
the Notch signaling pathway. A lack of either one perturbs Notch
signaling, resulting in hydrocephalus, which suggests the importance
of Notch signaling integrity in the pathogenesis of hydrocephalus.
This study provides evidence that Rnd3 is a Notch signaling
antagonist. Rnd3 regulates Notch activity through posttransla-
tional regulation of NICD. It physically interacts with NICD and
facilitates NICD protein degradation. We propose a working
model in which Rnd3 functions as a NICD cofactor (Fig. 8),
binding to NICD and preventing NICD from forming a functional
complex with Maml and CSL in the cell nucleus. This process is
dynamically regulated. The down-regulation of Rnd3 releases
more NICD, which is then available for the formation of the
Fig. 5. Rnd3 physically interacted with NICD and facilitated its degradation.
(A) Coronal sections of a WT mouse aqueduct showed endogenous Rnd3
(green) and Notch1 (red) expression by immunofluorescent staining. (B and C)
Co-immunoprecipitation (IP) pull-downs were conducted, followed by immu-
noblotting analyses (IB). The blots confirmed the interaction of Rnd3 andNICD
proteins. (D) NICD protein levels in the entire Rnd3 expression vector trans-
fected cell lysates were measured by immunoblot analysis. Along with the
elevated Rnd3 protein levels, noticeable decreases in NICD protein levels were
observed; this effect was attenuated by treatment with a proteasome in-
hibitor, MG132. (E) Immunoblot analysis showed that the degradation of
endogenous NICD was enhanced by the introduction of Rnd3 when protein
synthesis was blocked by treatment with cycloheximide (CHX). h, hours.
Fig. 6. Genetic deletion of Rnd3 promoted aqueductal ependymal cell pro-
liferation, which was attenuated by treatment with compound E (Comp E). (A)
p-His3 was detected in Rnd3−/− aqueduct ependymal cells. The lower panels
were DAPI staining. (B) A noticeable increase in BrdU-positive cells (pink) was
observed in the HEK 293T cells treated with the siRNA specific for Rnd3 (siRnd3)
(upper right section of the image). This increase was attenuated by treatment
with compoundE (lower right sectionof the image). The BrdU-positive cellswere
quantified from nine images, taken from three slides, and presented in the lower
panel. (Scale bar: 25 μm.) *P < 0.05 vs. control siRNA (siControl) group.
Fig. 7. Inhibition of Notch signaling blocked the development of hydro-
cephalus. (A) The development of an enlarged lateral ventricle (LV) and third
ventricle (3V) induced by Rnd3 deficiency was prevented by treatment with
compound E (Comp E). (Scale bar: 1 mm.) (B) Aqueduct stenosis was not seen
in the brains of newborn Rnd3−/− mice after treatment with compound E.
Ce, cerebellum; Aq, aqueduct. (Scale bar: 200 μm.) (C) Expression levels of
Hes1 protein in the brain tissues of WT and Rnd3−/− mice were decreased by
treatment with compound E. (D) Quantified results from C. *P < 0.05 com-
pared with DMSO-treated WT mice.
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regulatory complex that hyperactivates Notch signaling. The lat-
ter promotes ependymal cell overgrowth, leading to aqueductal
stenosis or closure.
Although previous studies of the biological function of Rnd3
focused mostly on its inhibitory effect on the Rho kinase signaling
pathway, recent emerging evidence indicates that Rnd3 also par-
ticipates in the regulation of cell proliferation, consistent with our
results through different mechanisms. In fibroblasts, forced ex-
pression of Rnd3 blocked cell cycle progression at the G1 phase
through down-regulation of cyclin D1 (18). In prostate cancer
cells, Rnd3 expression induced the arrest of cells in the G2/M
phase by repressing cyclin B1 and cdc2 expression (19). Although
we cannot rule out the possibility that these cell-cycling regulatory
mechanisms by Rnd3 may apply to ependymal cells, this Rnd3
deficiency-mediated proproliferative effect is in line with our
findings. Moreover, the up-regulated Hes1 expression observed in
our Rnd3 knockdown studies also support Rnd3 as a factor in-
volved in cell proliferation, because Hes1 can inhibit p21 to pro-
mote cell proliferation (14).
In summary, we have demonstrated that Rnd3 is highly expressed
in ependymal cells of the CNS. Genetic deletion of Rnd3 results in
hyperplasia of the ependymal cells, causing aqueductal stenosis or
closure, in turn leading to the development of obstructive hydro-
cephalus. Rnd3 is a regulator of Notch. Genetic or siRNA knock-
down of Rnd3 attenuates NICD protein degradation, resulting in
increased Notch signaling activity, which then promotes cell pro-
liferation and contributes to the pathogenesis of hydrocephalus.
Inhibition of Notch activity is sufficient to rescue the Rnd3-medi-
ated hydrocephalus disorder in the mutant animals. The finding of
the effect of Rnd3 on NICD adds a regulatory layer of Notch sig-
naling. Given the fundamental role of the Notch pathway in cell
signaling and cell-to-cell communication, our findings indicate
a potential target for pharmacologic manipulations.
Materials and Methods
Generation of Rnd3 KO Mouse Lines and Assessment of Rnd3 Expression and
Hydrocephalus Disorder in Mice. We generated Rnd3 KO mice derived from
a Texas Institute for Genomic Medicine gene trap ES cell line. The targeting
Fig. 8. Proposedmodel outlining themolecular mechanism of the Rnd3 deficiency-mediated development of hydrocephalus. (A) On activation, Notch receptors
on ependymal cell membranes are cleaved into the intracellular isoformNICD,which is translocated into the nucleus. In the nucleus, Rnd3 controls the accessibility
of NICD protein toMaml and CSL by physically interactingwith NICD. In the absence of Rnd3, Notch signaling is significantly enhanced owing to the extra amount
of NICD available forMaml and CSL to form transcriptomes, which then facilitates ependymal cell proliferation, resulting in aqueduct stenosis and hydrocephalus.
(B) The process of aqueduct stenosis formation. Depletion of Rnd3 promotes ependymal cell proliferation through the enhanced Notch signalingmechanism. The
overgrowth of ependymal cells leads to the formation of multiple ependymal cell layers, inward cellular folding, and eventually luminal stenosis or closure.
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vector containing a lacZ-expressing cassette with an internal ribosomal entry
site was inserted into intron 2 of Rnd3. All animal experiments were ap-
proved by the Institutional Animal Care and Use Committee of the Texas
A&M Health Science Center-Houston.
The Rnd3 expression profile was assessed by lacZ staining in E9.5 het-
erozygous embryos, qPCR analysis, and immunostaining in WT adult (8-wk-
old) littermates. Hydrocephalus disorder was evaluated in 6- to 8-wk-old
mice. For the compound E rescue experiment, 10 pregnant Rnd3+/− mice at
E12.5 were given compound E (10 nmol/g/day i.p.; Adipogen) until birth, and
elimination of hydrocephalus disorder was assessed in postnatal day 3 (P3)
mice. The same amount of DMSO was administered to control groups. The
cell culture experiments used 10 μM compound E.
qPCR Analysis. Transcripts were quantified by qPCR analysis (StepOnePlus; Life
Technologies) using the SYBR Green method with a MasterMix buffer system
containing Taq polymerase, as described previously (20). Total RNA was
prepared by TRIzol extraction. The forward and reverse PCR primers were as
follows (5′ to 3′): Rnd3: CTATGACCAGGGGGCAAATA/TCTTCGCTTTGTCCTTT-
CGT; Notch1: GCAGTTGTGCTCCTGAAGAA/CGGGCGGCCAGAAAC; Hes1:
CGGACATTCTGGAAATGACA/CATTGATCTGGGTCATGCAG; GAPDH: GGTGAA-
GGTCGGTGTGAACGGATTT/GCAGAAGGGGCGGAGATGATGA. GAPDH expres-
sion levels were used for qPCR normalization. Expression levels were
determined by the 2-ΔΔCt threshold cycle method.
Immunostaining, Immunoblotting, and Immunoprecipitation. The following anti-
bodies were used for immunoanalyses: anti-Rnd3 (Cocalico Biologicals), anti-
Notch1 (Abcam; ab27526), anti-cleavedNotch1 (Valv 1744) (Cell Signaling; 2421),
anti-Hes1 (Abcam; ab71559), anti-pHis3 (Santa Cruz Biotechnology; sc-8656),
anti-c-Myc (9E10, Santa Cruz Biotechnology; sc-40), APC-conjugated anti-BrdU
antibody (BD; 552598). Protein loading for immunoblotting analysiswas verified
by the intensity of the GAPDH blot (Santa Cruz Biotechnology; sc-20357).
siRNA specific for Rnd3 was purchased from Thermo Scientific (L-007794-
00-0005). The myc-Rnd3 expression construct was generated with a pCMV-
Myc backbone (Clontech). The Flag-NICD construct was kindly provided by
Chundong Yu (Xiamen University, China).
β-Gal (lacZ) Staining. Brain tissues or mouse embryos at E9.5 were incubated in
the fixing solution consisting of 4% paraformaldehyde and 0.2% glutaral-
dehyde, and then stained by the lacZ staining solution containing 1 mg/mL
X-gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, and 2 mM MgCl2 in PBS.
Cell Culture, Gene Transient Transfection, and BrdU Staining Analysis. Human
embryonic kidney A293T (HEK 293T) cells were cultured in DMEM with 10%
FBS. All of the gene transient transfections were performed using the NEON
transfection system (MPK5000; Life Technologies). The final concentration of
50 μg/mL cycloheximide was applied in the cycloheximide chase experiment.
For BrdU staining analysis, cells were incubated with BrdU for 45 min before
being harvested. Images were acquired by fluorescence microscopy.
Microarray, Data Analysis, and Signaling Pathway Analysis. Total RNA was
isolated from the brains of 8-wk-old mice, and 0.5 μg was used for cDNA
preparation. The assessment was performed using the Qiagen RT2 Profile PCR
Array. Data analyses were performed with R (www.r-project.org), a publicly
available statistical tool for data analysis. Signaling pathway analysis was per-
formed with Ingenuity (www.ingenuity.com).
Statistical Analysis. Data are expressed as mean ± SEM. Multiple comparisons
were done using one-way ANOVA, followed by the Holm–Sidak method.
Two-group comparisons were done using the unpaired two-tailed Student
t test (SigmaPlot, version 11.0). A P value < 0.05 was considered significant.
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